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Background: From fetal life until cardiac surgery, complex congenital heart diseases (CHD) exhibit different he-
modynamic and oxygenation patterns that can lead to alteration of the metabolic profile. We used a metabolomic
approach to identify urine metabolic markers before cardiac surgery, aiming to define the physiology of patients
with complex CHD and to contribute to predict their neurodevelopmental outcome.
Methods: In a prospective, observational, single-center study we enrolled 28 patients with complex biventricular
and univentricular CHD aged less than 5 years, on stable hemodynamic conditions, and with no genetic anom-
alies. We analyzed urine samples, collected at the induction of anesthesia, by 1H NMR spectroscopy. Profiles of 1H
NMR spectra were submitted to unsupervised (principal component) and supervised (partial least squares-
discriminant) multivariate analysis. Neurodevelopment was assessed by neuropsychological and adaptive func-
tioning testing.
Results: Principal components analysis divided CHD patients metabolic profiles in two distinct clusters (RED and
BLACK). Metabolic profiles belonging to the RED cluster showed higher levels of accumulation of citric acid cycle
intermediates and glucose compared to the profiles in the BLACK cluster, indicating a possible switching to
anaerobic metabolism. Patients belonging to the RED cluster were significantly more prone to show an adverse
neurodevelopment pattern (p ¼ 0.01).
Conclusions: The application of metabolomic analysis to CHD children permitted a deeper insight on their
metabolic status that could help to obtain a better understanding of the physiological implications and to predict
long-term neurodevelopmental outcome.1. Introduction
Congenital heart diseases (CHD) are the most common congenital
defects, affecting nearly 1% of all newborns [1]. There are different types
of CHD involving the abnormal development of the right or left ven-
tricular outflow tract of the heart septation. This implies an altered bloodonato).
1 June 2019; Accepted 26 Septem
is an open access article under tflow and oxygen delivery to the tissues during fetal and neonatal life,
leading to organ dysfunctions, including the brain. About 25% of chil-
dren with a CHD are critical and life-saving surgical correction is
employed in the first months of life [2]. These children are at risk of
suboptimal developmental outcome as consequence of cardiac surgery
[3], although there is an increasing awareness that CHD patients mayber 2019
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alterations in early stages of brain development independently from
surgical procedures [6].
Despite medical advancements have increased the survival rate of
CHD patients, the incidence of neurodevelopmental sequelae remains
high [7, 8], since patients without neuro-motor impairments may exhibit
subtle cognitive difficulties in several domains, such as visuospatial, in-
formation processing speed, language and communication, attention,
and social skills [8, 9].
Overall, several studies demonstrated that children with CHD are at
high risk to develop a wide spectrum of neurodevelopmental sequelae
but early prognostic indicators are lacking. The assessment of the
untargeted metabolic profile (metabolomics) could be used as biomarker
of impaired neurological outcome and specific metabolites can be iden-
tified after an initial untargeted screening. This approach has been used
in a wide range of diseases, including surgical oncology, sepsis, obesity,
and malnutrition [10, 11, 12]. Types and amounts of metabolites are
influenced by various physiological and pathological stimuli including
age, gender, drugs, toxins, and diseases. New developments in metabolic
profiling techniques such as nuclear magnetic resonance (1H NMR)
spectroscopy and mass spectrometry have opened up the possibility to
build a picture of the metabolic environment in cells, tissues, or biofluids.
Typical analytical samples for metabolomic studies are easily accessible
fluids (i.e. plasma/serum or urine) and their metabolome represents the
end-product of genetic fingerprinting, thus providing a more complete
characterization of cell phenotype than genome, transcriptome, and
proteome [13].
In this study, we correlate the metabolic profile of urine samples
collected before cardiac surgery in patients with CHD with their long-
term neuropsychological outcome. We selected various CHD types, in
order to increase the generalizability of results across heart defects. We
hypothesized that metabolic profiles could reflect the physiological sta-
tus before surgery and could contribute predicting clinical and neuro-
developmental outcome.
2. Materials and methods
2.1. Patients
This is a prospective, observational, single-center study in children
with CHD. The study was approved by the Institutional Review Board
and Ethics Committee, Padova University Hospital. Inclusion criteria
were: children with complex CHD that would require a cardiopulmonary-
bypass (CPB) during surgery; elective cardiac surgery (patient on spon-
taneous breathing before surgery), stable hemodynamic conditions
(constant inotropic support if needed, no volume load at admission or
during the hospital stay prior to surgery), and written informed consent
obtained from parents/legal guardians. Exclusion criteria were: age >5
years, liver damage defined as coagulation factor V<20%, kidney failure
with creatinine clearance <30%, and preoperative diagnosis of chro-
mosomal abnormalities.
We prospectively collected the following demographic data and
clinical outcome parameters: birth weight, gestational age, gender,
weight and age at the time of surgery, presence of hypoxia (defined as
arterial oxygen saturation <90%, recorded before surgery), pre-surgery
oxygen saturation, cerebral regional saturation, plasma arterial lactate,
intensive care unit and hospital length of stay, and survival.
2.2. Sample collection and analysis
A urinary catheter was placed after induction of anesthesia in the
operating room before cardiac surgery. Samples were collected from the
urinary reservoir, aliquoted, and immediately stored at 80 C until
analysis.22.3. 1H NMR spectroscopic analysis
NMR measurements were carried out on a Bruker DRX 600 MHz
Avance Spectrometer equipped with a Selective Inverse Probe (SEI)
equipped with Z gradient coil Spectra were acquired at the constant
temperature of 298.0  0.1 K by using a 90 pulse. A 10 s delay was
included in the pulse sequence to allow T1 relaxation. In fact, T1 values
(in the range 1.5–2.8 s) of the considered metabolites are such that a 10 s
delay allows full recovery of longitudinal magnetization after a 90 pulse,
as verified by constant integral values for D1 5 s. A 0.3 Hz line
broadening function was applied before Fourier transformation. Sup-
pression of the water signal was achieved by applying a saturation pulse
of 2 s duration at the water resonance. 32k data points per scan were used
and 128 transients were accumulated. Samples were prepared as
described by Groenen et al. [14]. For deproteinization, 2 ml of the sample
was centrifuged over a 10 KDa filter for½ h at 3000 x g (10 kDa Sartorius
AG, Goettingen, Germany), pre-washed with 6 ml of NaOH 0.01 N and
with 8 ml of water to avoid contamination with glycerol, always present
in commercial membranes. 550 μl of filtrate plus 50 μl of a TSP-d4 20mM
solution were measured into a 0.5 mm (outer diameter) NMR tube. All
spectra were run at 2.50  0.02 pH measured with a microelectrode. The
chemical shift of ionizable substances is highly dependent on pH. At pH
2.50 all chemical shift values are reproducible within 0.01 ppm 10.
Moreover, under these conditions, the methyl signals of creatine and
creatinine are clearly separated (3.05 ppm for the methyl signal of cre-
atine and 3.13 ppm for creatinine) and the methyl signal of lactic acid
(1.41 ppm) is not overlapped by the methyl resonance of threonine (1.33
ppm). The pH was adjusted with a minimal volume of HCl, starting from
a 3 M and ending with a 0.05 M.
2.4. Outcome assessment
At least 18 months after surgery, a brief neuropsychological exami-
nations and an evaluation of the adaptive functioning were conducted by
a psychologist trained in test administration and scoring.
2.4.1. Neuropsychological testing
The following neuropsychological tests were used: the Raven Colored
Matrices [15]., which evaluates abstract reasoning and allow an estimate
of general cognitive functioning; the visual attention test of the NEPSY-II
[16, 17]; the Coding test of the WISC-IV [18], which evaluates working
memory, manual dexterity and attention; the visual-motor integration
test [19], which evaluates visual-motor integration abilities. The entire
test battery required nearly 1 h to be completed.
2.4.2. Adaptive functioning
Adaptive functioning was assessed by the administration to parents of
the Vineland Adaptive Behavior Scales (VABS-I) [20], which is a psy-
chometrically validated interview that assesses adaptive behaviors at
developmental levels from birth through adulthood. Several domains are
evaluated, yielding index scores for socialization, communication, daily
living, and motor skills (for children up to age 5). Each domain includes
several subdomains with developmentally sequenced items, starting with
skills typically observed in infancy.
2.5. Data reduction and multivariate analysis
Pareto scaling has the advantage, over the classical autoscaling pre-
processing procedure, of boosting the importance of smaller peaks,
without increasing instrumental noise in a significant way. In the pre-
processing step, NMR spectra are phase and baseline corrected, using a
weighted least square second order polynomial regression, and refer-
enced to TSP (δ 0.0 ppm) position. Then data have been aligned bymeans
of an open source algorithm, iCOSHIFT [21], which is based on rigid shift
of intervals and which uses Fast Fourier Transform computation to boost
the simultaneous alignment of all spectra in a dataset. At the end of the
L. Vedovelli et al. Heliyon 5 (2019) e02547pre-processing, useless spectrum parts, like the high field and the very
low field, plus the central part (about 4.80–5.20 ppm), where the water
resonates, are removed.
In order to analyze the differences in metabolic profile that are
correlated to the different patients' status, we used a two-step analytical
procedure. First we used a Principal Components Analysis (PCA) [22,
23], an unsupervised technique that it is generally used to find trajec-
tories and clustering, then Partial Least Square Discriminant Analysis
(PLSDA) was used for data modelling. PLSDA [24] was carried out with
the R package ‘pls’ [25]. The “leaving one out” cross validation deter-
mined the optimal number of components. PLSDAmodels are reported in
term of the coefficients of determination calculated both from the fitted
values on the overall dataset (R2cal) and on the cross-validated one.
Feature selection has been accomplished using variable importance
values in the projection (VIP), computed according to Chong Il-Gyo and
Jun Chi-Hyuck's definition [26].
2.6. Neuropsychological data
Scores for the neuropsychological and adaptive results were age-
corrected and converted into z, scaled or standard scores, as appro-
priate, using published normative data. The z scores indicate the devia-
tion from the mean population score, which is set to 0, standard deviation
1. A z score of -2 (or less) comprises 2.5 % of the normal distribution and
is considered to be significantly lower than average. Scaled scores indi-
cate the deviation from the mean population score, which is set to 10,
standard deviation 3. A scaled score of 4 (or less) is considered to be
significantly lower than average. Standard scores have an age-referenced
mean (intelligence quotient, IQ) of 100 and a standard deviation of 15. A
standard score of 70 (or less) is considered to be significantly lower than
average.
Regarding to neuropsychological testing, Clinical Index (CI) of
dysfunction was calculated for each patient considering impairments of
single functions: we classified as dysfunction if a patient obtained an
impaired score (<2 standard deviations) on at least two cognitive tasks or
VABS-I subscales (i.e. of socialization, communication, daily living, and
motor skills). This methodology provided dichotomous values and it is
useful in order to quantify a wide range of impairments in a unitary
measure (a single, dichotomous score from different tests). Fisher's Exact
test was used for dichotomous variables. Positive predictive value (PPV),
negative predictive value (NPV), sensitivity, specificity, and accuracy
were calculated in order to evaluate the prognostic value of
metabolomics.
3. Results
3.1. Patients
Twenty-eight children with CHD were studied in the Pediatric Car-
diovascular Surgery Unit, “V. Gallucci” center, Padova University Hos-
pital, Italy. Eleven patients presented with a main diagnosis of tetralogy
of Fallot (TOF), 3 had septal defects (ventricular or atrial, VSD/ASD), 6
had transposition of the great arteries (TGA), and 8 had diagnosis of
univentricular heart. Four children died, 3 during or immediately after
surgery and 1 later for non-surgical related cause.Table 1
Clinical details on the patient clinical variables.
Clinical variable All (n ¼ 28) TGA (n ¼ 6)
Age (months) 3.0 (0.4–6.5) 0.3 (0.2–1.2)
Gender (M/F) 14/14 0/6
SaO2 (%) 88 (85–95) 87 (82–92)
Cerebral saturation (rO2) 55 (45–63) 52 (45–60)
Blood pH before surgery 7.42 (7.34–7.49) 7.45 (7.37–7.55)
Serum Lactate before surgery (mmol/L) 1.10 (0.80–2.06) 2.18 (1.66–2.84)
Data are expressed as median (interquartile range) or median (min - max) for septum
3Median age at cardiac surgery was 3.0 (0.4–6.5) months, and median
weight was 4.8 (3.4–6.6) kg. They had impaired growth, with a median
weight-to-age zscore of -1.4 (-2.5, -0.5). Clinical details are shown in
Table 1.
3.2. PCA loading scores
In Fig. 1, we reported the grouping obtained using only pre-surgery
clinical characteristics. Oxygen-related variables are the main factors
affecting clustering, revealed mainly along the first principal component
(PC1) axis. Hypoxia, defined as preoperative arterial saturation <90 %,
was first selected for a rough classification and was then refined through
the actual oxygen saturation (second principal component, PC2 axis). All
CHD, except TOF, tended to form a compact cluster and outliers could be
explained by definite clinical characteristics (e.g. particularly complex
heart anatomy or comorbidity).
TOF patients (red) are distributed along the PC1 axis reflecting the
heterogeneity of the disease. These patients are distinguished as normo-
saturated (on the right side) vs. hypoxic TOF (left side of PC1 axis) ac-
cording to their oxygen saturation recorded before surgery. VSD/ASD
(green) are clustered on the right side of the graph and they are therefore
not hypoxic (normoxic) subjects. Instead, on the left of the graph are
grouped all hypoxic CHD infants. Within this group, there are three types
of CHD: TGA and Norwood patients that have a similar pattern, and
Fontan patients that are in the highest part of the Fig. 1 because of their
higher weight.
3.3. NMR spectra
PCA clustering of urinary NMR spectra resulted in two distinct
metabolic profiles, represented as RED and BLACK profiles in Fig. 2, that
identifies two groups of infants. Glucose, sucrose, acetate, formate,
lactate, succinate, alpha-ketoglutarate, creatine, and urea were the
compounds over-represented in the RED cluster. Metabolic profiles
belonging to the RED cluster showed higher levels of accumulation of
citric acid cycle intermediates and glucose compared to the profiles in the
BLACK cluster, indicating a possible switching to anaerobic metabolism.
These infants’ clusters did not correspond to the pre-surgery clinical
clusters depicted in Fig. 1. Moreover, metabolic clustering was not
associated with the type of CHD, oxygen saturation before surgery, or age
(data not shown).
3.4. Neurodevelopmental outcome
We were able to administer the brief neuropsychological battery and
VABS-I interview to 19 out of 24 patients alive at the 18 months follow-
up after cardiac surgery: five parents refused the interview or were
unreachable.
By considering individual impairments, 52% of the children obtained
an impaired score to at least one subscale of the VABS-I, 9% to the Raven
Colored Matrices, 17% to the visual attention test, 33% to the Coding
test, 9% to the visual-motor integration test.
Considering the CI, 11/12 children in the RED metabolic cluster vs 2/
7 in the BLACK cluster meet the criteria of neuropsychological dysfunc-
tions (Table 2, Fig. 3). The two patients meeting criteria ofTOF (n ¼ 11) Septal defects (n ¼ 3) Univentricular (n ¼ 8)
3.3 (2.8–5.2) 0.4 (2.3–4.4) 8.0 (0.4–39.0)
7/4 3/0 4/4
94 (89–94) 88 (95–97) 85 (72–88)
57 (52–63) 43 (45–48) 58 (41–66)
7.41 (7.34–7.48) 7.42 (7.43–7.80) 7.40 (7.31–7.47)
0.84 (0.71–1.22) 0.88 (1.00–2.97) 1.07 (0.91–1.65)
defects. TGA: transposition of the great arteries; TOF: tetralogy of Fallot.
Fig. 1. Principal component analysis (PCA) loadings and scores. A: Transposition of the great arteries; B: Tetralogy of Fallot; C: Septum defects; D: Hypoplastic left-
heart syndrome - Norwood first stage surgery; E: Hypoplastic left-heart syndrome - Fontan surgery. Left panel represents variables (clinical characteristics) used for
PCA scoring, while right panel represents patients collocation based on their clinical characteristics. PC1 and PC2: principal component 1 and 2.
Fig. 2. Principal component analysis (PCA) of NMR spectra. NMR spectra
reflecting the metabolites composition of urines in each patient were analyzed
with an unsupervised method (PCA) resulting in a classification of CHD patients
in two distinct clusters (RED and BLACK). PC1 and PC2: principal component 1
and 2.
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impairment in daily abilities and in social functioning.
The diagnostic performance of metabolic clustering on impairments
of neuropsychology were: PPV 92%, NPV 71%, specificity 83%,Table 2
Cross tabulation of children with impaired and normal Clinical Index with
respect to metabolic clustering.
Metabolic cluster Clinical index Total
Normal Impaired
BLACK 5 2 7
RED 1 11 12
Total 6 13 19
RED and BLACK refer to the dichotomous classification of patients obtained by
the analysis of urinary NMR spectra.
4sensitivity 85% and overall accuracy 84%, p ¼ .01 (Fisher's Exact test).
4. Discussion
In this study, we enrolled patients with the major CHD diseases and
we cluster them according to urine NMR metabolomic analysis. The
metabolic clustering showed a good prognostic performance on neuro-
developmental outcome, with both high sensitivity and specificity.
CHD children represent a unique model for biomarker testing and
validation since most of them undergo elective, mostly standardized,
surgery after prenatal diagnosis [27]. CHD are a heterogeneous group of
diseases that, in our case, were not particularly linked to a single genetic
mutation or common group of mutations. Metabolomics was previously
successfully employed to detect foetuses with CHD using only a single
sample of maternal serum. This method seemed to be more effective than
ultrasound screening (the current standard for diagnosis) in detecting
CHD [28].
Here we applied a metabolomic approach in an exploratory pilot
study designed to test a classification that could predict the neuro-
developmental outcome of CHD patients, enhancing the anatomical-
clinical and morphological classification.
Our data suggest that NMR spectra predict the infants’ neuro-
development in a better fashion than their anatomical and/or clinical
classification. In fact, we did not identify a single or group of clinical
variables, such as pre-operative oxygen saturation or CHD type, able to
reflect the classification obtained from the NMRmetabolic profile. This is
in line with the assumption that metabolome is the most “up-to-date”
insight on the status of the system, compared to proteomics and genomicsFig. 3. Clinical Index of neurodevelopment. Clinical Index (CI) of dysfunction
was calculated for each patient considering impairments of single functions in
neurodevelopmental testing. RED and BLACK refer to the clustered classification
of patients obtained by the principal component analysis of metabolomic uri-
nary NMR spectra. p ¼ .01 (Fisher's Exact test).
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involving an accumulation of citric acid cycle intermediates and glucose,
indicated a shift toward the anaerobic metabolism typical of cyanotic
patients. Since key cluster-defining metabolites were from the energy
metabolism, we firstly speculated that oxygen saturation could explain
themajority of the clustering obtained by NMR spectra analysis but it was
not true. This is probably due to the fact that the overall chronic
oxygenation status is not precisely described by the oxygen saturation
near surgery, and thus metabolomics could help to have a more precise
look into energy metabolism modification rather than a mere oxygen
saturation measurement.
An accurate determination of the risk of neurodevelopmental ab-
normalities in this population is challenging, but our data support the
hypothesis of a prognostic role of metabolomics on neurodevelopment.
Metabolite clustering demonstrated to correctly identify the majority of
children with neurodevelopmental sequelae (sensitivity 85%), while
maintaining a low rate of children incorrectly defined as not impaired
(NPV 71%). Since sensitivity increases as the number of false negatives
reduces, it represents a useful index especially in those mild-moderate
cases in which other reliable clinical or instrumental prognostic in-
dicators are lacking.
In children who underwent surgery for complex CHD, a wide spec-
trum of neuro-cognitive deficits have been reported at the beginning of
school age (about 50%) [30], with differential effects of the severity of
CHD emerging gradually over time [7, 31]. The etiology of neuro-
developmental sequelae is not well understood, but neuroimaging and
neurodevelopmental studies have identified an altered brain maturation
with a disruption of cognitive network as a probable cause [8]. The ce-
rebral damage could originate in utero and before surgery from disorders
of cerebral blood flow due to the heart condition [8], in a period of
crucial importance for the development of the nervous system. In
severely hypoxic children the lack of ketone production could act in two
ways toward brain injury: depriving the brain of its principal anaerobic
source of energy, and taking away a neuroprotective class of molecules
possibly exposing the brain to further insults during surgery (i.e. car-
diopulmonary bypass) [9]. Given the immaturity of the nervous system at
this stage, the real effects of these processes on cortical circuitries are not
evident since several years after the cerebral damage, as more complex
functions emerge, revealing the underlying neurobiological vulnera-
bility, as shown in other pathological conditions [32].
Moreover, late identification of ongoing abnormal neuro-
development, often at school age, means that an important opportunity
for therapeutic interventions during the early formative developmental
window may be lost. Early identification of children at risk of developing
neurodevelopmental sequelae is crucial for interventions and rehabili-
tative programs: in early infancy changes on brain circuitry and on
cortical refinement can still occur; at this time the milestones at the
bottom of subsequent maturation of more complex cognitive abilities
were posed. In the absence of interventions, disrupted cerebral circuitries
may undergo a cumulative effect on ongoing development, showing a
worsening of cognitive functioning during childhood [33].
No different clinical outcome (i.e. ICU stay, total length of stay, and
duration of mechanical ventilation) was observed among the clusters.
Moreover, all patients that died in the post-surgery period (n ¼ 3) are
grouped in the BLACK metabolic cluster suggesting that surgical chal-
lenges and complex physiological interactions may still be important
factors that influence the overall short-term outcome of surgery.
Major limitations of this study were the small number of patients that
precluded a deeper analysis of CHD children metabolism and neuro-
developmental outcome in different diseases and through the same dis-
ease. Moreover, an external validation in an independent cohort is
lacking.
In conclusion, we found that metabolic profile before CHD surgery
could be useful for providing a more precise classification of CHD pa-
tients based on their neurodevelopmental outcome, possibly enhancing
the anatomical-clinical and morphological classification. This5classification, once validate in a larger cohort, could be useful to stratify
CHD children for their neurodevelopmental risk in order to plan timely
interventions aimed to minimize their burden.
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